NASDAQ: NXTCNextcure Inc Stock Ownership - Who owns Nextcure?
Insider buying vs selling
Have Nextcure Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NXTC insiders and whales buy or sell their stock.
NXTC Shareholders
What type of owners hold Nextcure Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Chau Quang Khuong | 9.68% | 2,711,013 | $978.68k | Insider |
| Orbimed Advisors LLC | 9.68% | 2,711,013 | $978.68k | Insider |
| Sofinnova Venture Partners IX LP | 9.54% | 2,671,856 | $964.54k | Insider |
| Sofinnova Investments Inc | 9.54% | 2,671,856 | $964.54k | Institution |
| Affinity Asset Advisors LLC | 8.22% | 2,302,598 | $831.24k | Institution |
| Timothy M. 1. Shannon | 8.05% | 2,254,442 | $813.85k | Insider |
| Canaan X LP | 8.05% | 2,254,442 | $813.85k | Insider |
| Pfizer Inc | 5.21% | 1,458,550 | $526.54k | Institution |
| Citigroup Inc | 4.96% | 1,389,040 | $501.44k | Institution |
| Orbimed Advisors LLC | 4.07% | 1,141,200 | $411.97k | Institution |
NXTC vs Biotech Stocks
Nextcure Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.